Experts to review diabetes drug over link to cancer

Medical experts are reviewing the safety of drug widely used to treat diabetes after experts linked it to pancreatic cancer.

Researchers have suggested that there could be a link between the disease and incretin mimetics, which are used to treat type 2 diabetes by regulating blood sugar.

Earlier this year, experts in Europe and America launched a review into the safety of the drugs.